Renewed Concept of Mastoid Cavity Obliteration with the Use of Temporoparietal Fascial Flap Injected by Injectable Platelet-Rich Fibrin after Subtotal Petrosectomy for Cochlear Implant Patients
A. Zwierz, K. Masna, Paweł Burduk, Stephan Hackenberg, Matthias Scheich
{"title":"Renewed Concept of Mastoid Cavity Obliteration with the Use of Temporoparietal Fascial Flap Injected by Injectable Platelet-Rich Fibrin after Subtotal Petrosectomy for Cochlear Implant Patients","authors":"A. Zwierz, K. Masna, Paweł Burduk, Stephan Hackenberg, Matthias Scheich","doi":"10.3390/audiolres14020025","DOIUrl":null,"url":null,"abstract":"Background: The subtotal petrosectomy procedure may be useful for cochlear implantation in selected patient groups. Although it is highly effective, complications can arise, which may have economic implications for the patient due to the high cost of the device. Therefore, several authors have attempted to identify the most effective concept for obliteration. Methods: We present a pilot descriptive study of application techniques for obliterating cavities after subtotal petrosectomy using a temporoparietal fascial flap (TPFF) modified with injectable platelet-rich fibrin (IPRF+) for three cochlear implant (CI) patients. Results: Our concept preserves important anatomical structures, such as the temporalis muscle, which covers the CI receiver–stimulator. Injection of IPRF+ also increases the available tissue volume for obliteration and enhances its anti-inflammatory and regenerative potential. Conclusions: To the best of our knowledge, the use of TPFF for filling the cavity has not been adopted for CI with SP and for blind sac closure. Our literature review and our experience with this small group of patients suggest that this procedure, when combined with IPRF+ injections, may reduce the risk of potential infection in the obliterated cavity, particularly when used with CI. This technique is applicable only in cases when the surgeons are convinced that the middle ear cavity is purged of cholesteatoma.","PeriodicalId":44133,"journal":{"name":"Audiology Research","volume":null,"pages":null},"PeriodicalIF":2.1000,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Audiology Research","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3390/audiolres14020025","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"AUDIOLOGY & SPEECH-LANGUAGE PATHOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Background: The subtotal petrosectomy procedure may be useful for cochlear implantation in selected patient groups. Although it is highly effective, complications can arise, which may have economic implications for the patient due to the high cost of the device. Therefore, several authors have attempted to identify the most effective concept for obliteration. Methods: We present a pilot descriptive study of application techniques for obliterating cavities after subtotal petrosectomy using a temporoparietal fascial flap (TPFF) modified with injectable platelet-rich fibrin (IPRF+) for three cochlear implant (CI) patients. Results: Our concept preserves important anatomical structures, such as the temporalis muscle, which covers the CI receiver–stimulator. Injection of IPRF+ also increases the available tissue volume for obliteration and enhances its anti-inflammatory and regenerative potential. Conclusions: To the best of our knowledge, the use of TPFF for filling the cavity has not been adopted for CI with SP and for blind sac closure. Our literature review and our experience with this small group of patients suggest that this procedure, when combined with IPRF+ injections, may reduce the risk of potential infection in the obliterated cavity, particularly when used with CI. This technique is applicable only in cases when the surgeons are convinced that the middle ear cavity is purged of cholesteatoma.
背景:在特定患者群体中,次全耳蜗切除术可能有助于人工耳蜗植入。虽然该手术非常有效,但也可能出现并发症,由于该装置成本高昂,可能会对患者造成经济影响。因此,多位学者试图找出最有效的阻塞概念。方法:我们为三位人工耳蜗(CI)患者进行了一项试验性描述性研究,研究内容是使用颞顶筋膜瓣(TPFF)和可注射富血小板纤维蛋白(IPRF+)修整人工耳蜗次全切除术后的腔隙阻塞应用技术。结果:我们的概念保留了重要的解剖结构,如覆盖 CI 接收刺激器的颞肌。注射 IPRF+ 还增加了可用于阻塞的组织体积,并增强了其抗炎和再生潜力。结论:据我们所知,使用 TPFF 填补腔隙尚未被用于带 SP 的 CI 和盲囊闭合。我们的文献综述和对这一小群患者的经验表明,该方法与 IPRF+ 注射相结合,可降低阻塞腔内的潜在感染风险,尤其是在与 CI 一起使用时。这项技术仅适用于外科医生确信中耳腔内胆脂瘤已被清除的病例。
期刊介绍:
The mission of Audiology Research is to publish contemporary, ethical, clinically relevant scientific researches related to the basic science and clinical aspects of the auditory and vestibular system and diseases of the ear that can be used by clinicians, scientists and specialists to improve understanding and treatment of patients with audiological and neurotological disorders.